فضلا اضغط بالاسفل
يستعمل دواء ثرومبونورم 0.5مجم 100 كبسولthrombonorm 0.5mg 100caps. thrombocythemia thrombocythemia
indication: -for the treatment of patients with thrombocythemia secondary to myeloproliferative disorders to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events. - -dosage: -adult- the recommended starting dose is 0.5 mg qid or 1 mg bid (2 capsules of 0.5 mg twice a day) and can be increased to 4 times daily. - -mechanism of action : -the mechanism by which anagrelide reduces blood platelet count is still under investigation. studies in patients support a hypothesis of dose-related reduction in platelet production resulting from a decrease in megakaryocyte hypermaturation. in blood withdrawn from normal volunteers treated with anagrelide a disruption was found in the postmitotic phase of megakaryocyte development and a reduction in megakaryocyte size and ploidy.
تركيبة دواءثرومبونورم 0.5مجم 100 كبسولthrombonorm 0.5mg 100caps.
يتركب هذا الدواء من :anagrelide
الشركة المنتجة لدواءثرومبونورم 0.5مجم 100 كبسولthrombonorm 0.5mg 100caps.
هذا الدواء من انتاج شركة marcyrl co.
جرعة دواءثرومبونورم 0.5مجم 100 كبسول
Welcome to Dlildwa, specifically the page of thrombonorm 0.5mg 100caps..
تم استعراض بدائل هذا الدواء 356 مرة